EDEN Bioscience Corporation
11816 Northcreek Parkway N.
Bothell
Washington
98011
United States
Tel: 425-806-7300
Fax: 425-806-7400
Website: http://www.EDENbio.com/
Email: rabinse@edenbio.com
20 articles about EDEN Bioscience Corporation
-
EDEN Bioscience Vaccine Expert to Speak at BioProcess International Conference & Exhibition
9/15/2010
-
EDEN Bioscience Announces Voluntary Delisting From Nasdaq and Filing of Articles of Dissolution
6/19/2009
-
EDEN Bioscience Announces Voluntary Delisting From Nasdaq and Filing of Articles of Dissolution
6/18/2009
-
EDEN Bioscience Announces Shareholders' Approval of Plan of Dissolution and Liquidation
5/21/2009
-
EDEN Bioscience Mails Definitive Proxy Materials for Special Meeting of Shareholders Scheduled for May 20, 2009
4/3/2009
-
EDEN Bioscience Announces Board of Directors' Approval of Plan of Dissolution and Liquidation
12/5/2008
-
EDEN Bioscience Effects 1-for-3 Reverse Stock Split
2/25/2008
-
EDEN Bioscience Receives Delisting Warning Letter From Nasdaq
9/18/2007
-
EDEN Bioscience Adopts Shareholder Rights Plan
6/4/2007
-
EDEN Bioscience Announces Today That Dr. Jean-Philippe Lemaire Presented the Latest Generation of Lumbar Disc Prosthesis at the American College of Spine Surgery
5/15/2007
-
EDEN Bioscience Completes Sale of Harpin Protein Technology Assets
3/1/2007
-
EDEN Bioscience Shareholders Approve Asset Sale
2/26/2007
-
EDEN Bioscience Receives Delisting Warning Letter From Nasdaq
12/13/2006
-
EDEN Bioscience Announces Third Quarter 2006 Financial Results
11/3/2006
-
EDEN Bioscience Regains Compliance With Nasdaq Minimum Bid Price Listing Requirement
10/30/2006
-
EDEN Bioscience Announces Second Quarter 2006 Financial Results
8/4/2006
-
EDEN Bioscience Announces First Quarter 2006 Financial Results
5/5/2006
-
EDEN Bioscience Effects 1-For-3 Reverse Stock Split
4/19/2006
-
EDEN Bioscience Receives Delisting Noticee
4/5/2006
-
EDEN Bioscience Announces Fourth Quarter And Year End 2005 Financial Results
2/23/2006